A landmark study examining drug use on mass transit — including Colorado's Regional Transportation District (RTD) — may help ...
The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...
The Physicians Committee for Responsible Medicine applauds the Food and Drug Administration’s newly released draft guidance, ...
A strategy to address crime and social dysfunction in the downtown core has continued to yield results, including a sharp ...
Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.
WHO endorses GLP-1 drugs for obesity treatment, emphasizing diet and exercise while advocating for equitable access worldwide ...
News-Medical.Net on MSN
Cystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatments
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...
On , The US Food and Drug Administration issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes six-month toxicity testing in non-human primates ...
Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor ...
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...
AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback